Epithelial and mesenchymal CTC detection in triple negative breast cancer patients using ANGLE's Parsortix®system

被引：0
|
作者：
Mezni, Amina [1 ]
Hardy, Matthew [1 ]
Ciccioli, Mariacristina [1 ]
Pailhes-Jimenez, Anne-Sophie [1 ]
机构：
[1] ANGLE Plc, Guildford, Surrey, England
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
969
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Role of epithelial–mesenchymal transition markers in triple-negative breast cancer
    Sai Yin Cheung
    Yvonne Jia Yu Boey
    Valerie Cui Yun Koh
    Aye Aye Thike
    Jeffrey Chun Tatt Lim
    Jabed Iqbal
    Puay Hoon Tan
    Breast Cancer Research and Treatment, 2015, 152 : 489 - 498
  • [2] PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
    Ghaneya Al-Khadairi
    Adviti Naik
    Remy Thomas
    Boshra Al-Sulaiti
    Shaheen Rizly
    Julie Decock
    Journal of Translational Medicine, 17
  • [3] PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
    Al-Khadairi, Ghaneya
    Naik, Adviti
    Thomas, Remy
    Al-Sulaiti, Boshra
    Rizly, Shaheen
    Decock, Julie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [4] Cancer stem cell (CSC) and epithelial mesenchymal transition (EMT) in triple negative breast cancer
    Ishikawa, Y.
    Oyama, T.
    Katayama, A.
    Handa, T.
    Tokiniwa, H.
    Horiguchi, J.
    Iino, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S123 - S123
  • [5] Evaluation of natural and synthetic compounds on epithelial to mesenchymal transition in triple negative breast cancer
    Faruk, Asef
    Patel, Saloni
    Hallak, Ramez
    Flaherty, Patrick
    Cavanaugh, Jane
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
  • [6] Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment
    Francesc Font-Clos
    Stefano Zapperi
    Caterina A. M. La Porta
    Scientific Reports, 12
  • [7] Role of epithelial-mesenchymal transition markers in triple-negative breast cancer
    Cheung, Sai Yin
    Boey, Yvonne Jia Yu
    Koh, Valerie Cui Yun
    Thike, Aye Aye
    Lim, Jeffrey Chun Tatt
    Iqbal, Jabed
    Tan, Puay Hoon
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 489 - 498
  • [8] Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer
    Haque, Mazharul
    Shyanti, Ritis K.
    Mishra, Manoj K.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Epithelial-mesenchymal transition promotes triple negative breast cancer immune suppression
    Williams, M. M.
    Christenson, J. L.
    O'Neill, K.
    Rogers, T. J.
    Greene, L. I.
    Slansky, J.
    Richer, J. K.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment
    Font-Clos, Francesc
    Zapperi, Stefano
    La Porta, Caterina A. M.
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345